These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 3964554)
41. Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease. Niemelä O; Risteli L; Sotaniemi EA; Risteli J Gastroenterology; 1983 Aug; 85(2):254-9. PubMed ID: 6602726 [TBL] [Abstract][Full Text] [Related]
42. Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease. Ergelen R; Akyuz U; Aydin Y; Eren F; Yilmaz Y Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):667-71. PubMed ID: 25923941 [TBL] [Abstract][Full Text] [Related]
43. Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis. Teare JP; Sherman D; Greenfield SM; Simpson J; Bray G; Catterall AP; Murray-Lyon IM; Peters TJ; Williams R; Thompson RP Lancet; 1993 Oct; 342(8876):895-8. PubMed ID: 8105167 [TBL] [Abstract][Full Text] [Related]
44. [The evaluation of serum type III procollagen-N-peptide on fatty liver in obese patients]. Ueno T; Nagata E; Miura T; Aso S; Ishii K; Yoshitake M; Noguchi K; Matsuzaki M; Wada T; Yamauchi K Nihon Shokakibyo Gakkai Zasshi; 1986 May; 83(5):999-1005. PubMed ID: 3747247 [No Abstract] [Full Text] [Related]
45. Procollagen type-III aminoterminal peptide in serum and synovial fluid of dogs with hip dysplasia and coxarthrosis. Madsen JS; Jensen LT; Strøm H; Hørslev-Petersen K; Svalastoga E Am J Vet Res; 1990 Oct; 51(10):1544-6. PubMed ID: 2240774 [TBL] [Abstract][Full Text] [Related]
46. [Serum type III procollagen peptide in tissue fibrosis]. Maruyama K Rinsho Byori; 1985 Jan; 33(1):27-32. PubMed ID: 3990010 [No Abstract] [Full Text] [Related]
47. [Levels of procollagen type III n-terminal peptide (PIIINP) in serum of patients with myeloproliferative syndrome (mps)]. Podolak-Dawidziak M; Wróbel T; Jeleń M Pol Arch Med Wewn; 1998 Jan; 99(1):24-9. PubMed ID: 9686500 [TBL] [Abstract][Full Text] [Related]
48. Determination of the aminoterminal peptide of procollagen type III and laminin P1 in serum of patients with chronic liver disease. Kárteszi M; Szalay L; Cornides A; Dávid K; Fehér J Acta Med Hung; 1988; 45(3-4):277-86. PubMed ID: 3249655 [TBL] [Abstract][Full Text] [Related]
49. Serum concentrations of the N-terminal propeptide of type III procollagen and two type IV collagen fragments and gene expression of the respective collagen types in liver in rats with dimethylnitrosamine-induced hepatic fibrosis. Savolainen ER; Brocks D; Ala-Kokko L; Kivirikko KI Biochem J; 1988 Feb; 249(3):753-7. PubMed ID: 3355495 [TBL] [Abstract][Full Text] [Related]
50. An immunohistochemical and serum ELISA study of type I and III procollagen aminopropeptides in primary biliary cirrhosis. Davis BH; Madri JA Am J Pathol; 1987 Aug; 128(2):265-75. PubMed ID: 3303951 [TBL] [Abstract][Full Text] [Related]
51. [Procollagen Type III-N-terminal peptide as an indicator of hepatic fibrogenesis]. Sajewicz Z; Poniewierka E Pol Tyg Lek; 1990 Apr 16-30; 45(16-18):325-6. PubMed ID: 2235718 [TBL] [Abstract][Full Text] [Related]
52. Serum concentrations of procollagen type III aminoterminal peptide in growing dogs with hip dysplasia. Madsen JS; Svalastoga E Acta Vet Scand; 1995; 36(1):157-60. PubMed ID: 7572455 [TBL] [Abstract][Full Text] [Related]
53. Procollagen Type I and III Aminoterminal Propeptide Levels and Severity of Interstitial Lung Disease in Mexican Women With Progressive Systemic Sclerosis. Gonzalez-Lopez L; Rocha-Muñoz AD; Olivas-Flores EM; Garcia-Gonzalez A; Peguero-Gómez AR; Flores-Navarro J; Villa-Manzano AI; Zavaleta-Muñiz SA; Salazar-Paramo M; Mejía M; Juárez-Contreras P; Vazquez-Del Mercado M; Cardona-Muñoz EG; Trujillo-Hernández B; Nava-Zavala AH; Gamez-Nava JI Arch Bronconeumol; 2015 Sep; 51(9):440-8. PubMed ID: 25301411 [TBL] [Abstract][Full Text] [Related]
54. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis. Schneider M; Voss B; Högemann B; Eberhardt G; Gerlach U Hepatogastroenterology; 1989 Dec; 36(6):506-10. PubMed ID: 2693303 [TBL] [Abstract][Full Text] [Related]
55. Validity of noninvasive markers of methotrexate-induced hepatotoxicity: a retrospective cohort study. Martyn-Simmons CL; Rosenberg WM; Cross R; Wong T; Smith CH; Barker JN Br J Dermatol; 2014 Aug; 171(2):267-73. PubMed ID: 24942271 [TBL] [Abstract][Full Text] [Related]
56. Decrease in serum levels of markers of hepatic connective tissue turnover during and after treatment of chronic hepatitis B with interferon-alpha. Teran JC; Mullen KD; Hoofnagle JH; McCullough AJ Hepatology; 1994 Apr; 19(4):849-56. PubMed ID: 8138256 [TBL] [Abstract][Full Text] [Related]
57. [Connective tissue polypeptides in serum: new parameters of connective tissue synthesis and degradation in liver fibrosis]. Schuppan D Z Gastroenterol; 1992 Mar; 30 Suppl 1():29-34. PubMed ID: 1449013 [TBL] [Abstract][Full Text] [Related]
58. Serum aminoterminal propeptide of type III procollagen in progressive systemic sclerosis and localized scleroderma. Zachariae H; Halkier-Sørensen L; Heickendorff L Acta Derm Venereol; 1989; 69(1):66-70. PubMed ID: 2563612 [TBL] [Abstract][Full Text] [Related]
59. Serum type III procollagen peptide: indicator for pulmonary fibrosis. I. A tool for early detection of pulmonary fibrosis as a complication in cancer therapy. Okazaki I; Miura K; Kobayashi Y; Maruyama K; Yoshimatsu H; Tanaka T Keio J Med; 1986 Jun; 35(2):107-15. PubMed ID: 3784237 [No Abstract] [Full Text] [Related]
60. Elevated procollagen-III-peptide in myositis ossificans progressiva. Kullich W; Klein G Clin Rheumatol; 1989 Dec; 8(4):542-3. PubMed ID: 2612126 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]